Tumor absorbed dose and outcomes after Y-90 glass radioembolization for colorectal liver metastases: does dose escalation improve survival in real-world practice?

Osman Melih Topcuoglu, Betul Uzunoglu, Tolga Orhan, Ismail Necim Yucel, Ayşegul Gormez, Turkay Toklu, Nalan Alan Selcuk · 2026

Read Tumor absorbed dose and outcomes after Y-90 glass radioembolization for colorectal liver metastases: does dose escalation improve survival in real-world practice? by Osman Melih Topcuoglu, Betul Uzunoglu, Tolga Orhan, Ismail Necim Yucel, Ayşegul Gormez, Turkay Toklu, Nalan Alan Selcuk (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13421275.txt.

Description

Osman Melih Topcuoglu and co-authors ask whether a higher radiation dose to tumors improves outcomes for people with colorectal cancer that has spread to the liver, in a 2026 study. The treatment sends tiny radioactive glass beads into the liver. All patients had cancer that no longer responded to standard drug care.

The team reviewed seventy-eight patients treated from 2014 to 2024 and split them by tumor dose at a set cut point. Survival and time without liver growth were much the same in the low and high dose groups. The share whose tumors shrank also did not differ. The authors conclude that raising the dose past that point did not extend life in this group, where heavy disease and spread outside the liver drove outcomes.

Catalog record

CREATOROsman Melih Topcuoglu, Betul Uzunoglu, Tolga Orhan, Ismail Necim Yucel, Ayşegul Gormez, Turkay Toklu, Nalan Alan Selcuk
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13421275

Browse the full library · About the Tower of Babel